Home/Filings/4/0001209191-19-016597
4//SEC Filing

Munoz Benito 4

Accession 0001209191-19-016597

CIK 0001445283other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:43 PM ET

Size

5.9 KB

Accession

0001209191-19-016597

Insider Transaction Report

Form 4
Period: 2019-03-01
Munoz Benito
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-03-01+123,950123,950 total
    Exercise: $4.30Exp: 2029-03-01Common Stock (123,950 underlying)
Footnotes (1)
  • [F1]These securities shall vest and become exercisable in a series of installments, with the first installment to become exercisable for 25% of the underlying common stock on February 5, 2020, and thereafter vesting and becoming exercisable in 12 quarterly installments as nearly equal as practicable (as determined by the Issuer in its reasonable discretion), until such stock option becomes fully exercisable on February 5, 2023, provided that the Reporting Person remains an employee of Issuer at all times during the applicable vesting period of such securities.

Issuer

PROTEOSTASIS THERAPEUTICS, INC.

CIK 0001445283

Entity typeother

Related Parties

1
  • filerCIK 0001661338

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:43 PM ET
Size
5.9 KB